SRB Ventures
3999 Mission Blvd, San Diego, CA, United States
Overview
SRB Ventures invests in a diversified portfolio of assets which are predominantly American listed companies.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Friendly Apps
Participated · Seed · May 2022
Founded by longtime engineer and product designer Michael Sayman, Friendly Apps aims to create a suite of mobile apps that prioritize users' physical and mental health over retention-driven social mechanics. Sayman draws on experience building products at Facebook, Google, Roblox and Twitter and plans to apply those learnings to healthier design choices. The company has not yet launched products; Sayman says he will test multiple product ideas, experiences and design elements before public releases. Early product concepts include an app to help casual users achieve fitness goals and an app to encourage prioritizing real-world relationships. Sayman plans to incorporate perspectives from immigrants and non-tech communities into product development. As a solo founder, he expects to have something released to the public in around six months.
- Arogga
Participated · Seed · Apr 2022
Arogga operates an app-based online pharmacy and health platform in Bangladesh, offering delivery of genuine, affordable medicines and healthcare products. The app lists over 32,000 medicines from more than 500 manufacturers and serves over 600,000 users. Features include prescription upload, medicine comparison, family profiles, rewards and discounts, referral credits, a request-medicine function, and chat-based customer support. The company is positioning the app as a comprehensive health solutions platform and aims to become a holistic health super app offering lab testing and doctor consultations. Arogga plans to launch a home lab testing service in November and to increase penetration in Dhaka while opening hubs in two other major cities by Q2 2024. The startup has raised capital to support regional expansion, product development, and operations. Arogga operates a digital health platform focused on door‑to‑door medicine delivery across Bangladesh, aiming to improve access to affordable, genuine pharmaceuticals. The company emphasizes combating counterfeit drugs, which the article notes affect over 20% of medicines in Bangladeshi pharmacies. Arogga was selected for and funded through Hyper’s Season 2022 program, gaining access to a four‑week founder curriculum and Hyper’s partner network. With this raise, the company plans to bolster its technology, product, and operational teams to grow and scale its service. The article highlights a large addressable market: Bangladesh’s pharmaceutical sector is estimated at $3.5 billion and projected to reach $6 billion by 2025. Co‑founders quoted in the article include CEO Rosina Mazumder and CTO Shamim Hasan, who framed the fundraise as a step toward nationwide impact. Arogga operates a tech-enabled medicine delivery service that offers genuine medication directly from manufacturers and delivers to consumers' doorsteps. Since launching in December 2020, the company has seen strong traction with a reported 60% average month-on-month growth. Operational metrics cited include over 70,000 app downloads, more than 30,000 medicines delivered, and a 4.9 user rating. Arogga won the Tech in Asia Pitch Competition in March, which attracted investment from Singapore-based angel investors. The team says it will use new funds to expand its tech talent and scale operations to build further verticals. Leadership emphasizes using technology to improve healthcare access across Bangladesh.
Team
No current team members are available.